IncFact
Company Profiler: Revenue, Growth, Competition

NEUROPACE

455 N. Bernardo Avenue
Mountain View, CA 94043

www.neuropace.com

Company Awards

Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 
VC / Private Equity
Venture Capital / Private Equity

Company Profile & Financial Information for Neuropace

Neuropace's revenue, profitability, growth rate by year. Trademarks and applications show Neuropace's marketing strategy. Precise revenue figures by year, number of employees, and trademarks indicate Neuropace's strengths. Neuropace operates in the Scientific Research & Development Services industry. A list of fastest growing competitors, and info on recession risks show Neuropace's weaknesses relative to its competitors.

Access the complete profile.


Fast Facts

Revenue$10 - $100 million    Exact Revenue in Premium Report
Employees100 - 1,000Exact Employee Count Available in Premium Report
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes33451
33911
Note: Revenues are statistical evaluations.


Neuropace's Business Operations Profile shows critical firmographic facts:
  • What is the company's size? (Revenue and employees)
  • What industry is the company in?

Neuropace Revenue and Growth Rate

Neuropace Revenue Est.
($ Million)
Growth Rate (%)# Employees
2015Details in Premium Report
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Neuropace's revenues are gauged from an analysis of company filings.



Investor Activity

Neuropace has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
August 8, 2017 26 90% $80 MM
Complete list of funding rounds and total amounts in the Company Report




Neuropace's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Neuropace Revenue (Sales) Neuropace Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications, moreso than trademark registrations, show the products and services that are developing and being actively marketed. Companies that don't have any trademark applications are more likely to be stable, maintaining their existing business lines. Companies that are applying for new trademarks are likely to be investing in R&D and marketing, attempting to expand more rapidly or pivoting to reach strategic markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
SIMPLESTART
Operating software to be embedded in medical apparatus for treating neurological disorders
04/06/2016
YOUR WINDOW TO THE BRAIN
Medical devices, namely, apparatus for treatment of neurological disorders
01/07/2016
TARGETED TREATMENT WHEN IT'S NEEDED
medical devices, namely, apparatus for treatment of neurological disorders
11/10/2014

See all trademarks in the Full Report.


Patent Applications

Patent applications show the company's intellectual property, as well as its current capabilities and future direction. Neuropace has applied for 95 patents since 2009. Neuropace's most recent patent was filed in July 2017 for Systems And Methods For Interacting With An Implantable Medical Device. An interactive implantable medical device system includes an implantable medical device and a network-enabled external device capable of bi-directional communication and interaction with the implantable medical device. The external device is programmed to interact with other similarly-enabled devices. The system facilitates improved patient care by eliminating unnecessary geographic limitations on implantable medical device interrogation and programming, and by allowing patients, physicians, and other users to access medical records, history, and information and to receive status and care-related alerts and messages anywhere there is access to a communications network.


Patent Application Date
Complete list of patent applications




Recession Risk

IncFact analyzed data from the last recession to determine whether Neuropace grew or shrank over that period. We also looked at other companies in the industry to compare how recession-proof Neuropace is relative to the industry. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Competition: Neuropace vs. Largest Competitors

A competitive analysis shows these companies are in the same general field as Neuropace, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
SCIENCE APPLICATIONS INTERNATIONMclean, VA100 
ALEXION PHARMACEUTICALSNew Haven, CT82 
CEPHALONFrazer, PA70 
VERTEX PHARMACEUTICALSBoston, MA68 
SANDIAAlbuquerque, NM63 




Nearby Competition

Info on companies that are located in close proximity to Neuropace, operating in similar markets. While some companies, particularly retail, compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Neuropace's CompetitorsRevenue ($ MM)
Neuropace Premium Report




Fastest Growing Competitors

These companies are in the same general field as Neuropace and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Neuropace Competitors